Trial Profile
Phase II trial in Japan of chidamide in patients with adult T-cell leukaemia/lymphoma.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 25 Mar 2015
Price :
$35
*
At a glance
- Drugs Tucidinostat (Primary)
- Indications Adult T-cell leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors HUYA Bioscience International
- 25 Mar 2015 New trial record